Previous 10 | Next 10 |
Allscripts Healthcare Solutions (NASDAQ:MDRX) said its director Paul Black sold about 140K shares at $17.30-$17.398, worth ~$2.4M. MDRX disclosed the share sale in a form 4 filing on Tuesday. Paul Black now owns about 2.7M shares in the company. MDRX stock earlier closed largely unchanged ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Covid-19 Dashboard highlights risk factors for unvaccinated, vaccination gaps, and social disparities Researchers from Veradigm ® , a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Piper Sandler analyst Jeff Garro lowers price target on Allscripts Healthcare Solutions (MDRX) -7% to $19 from $22 and keeps a neutral rating after the company reported Q1 results. Analyst further states that he needs to be more clear about visibility and competi...
R1 RCM Inc. provides services to increase medical provider reimbursements and is an industry that grows at 10.3% annually. Changing regulations and the need to scale medical care across America will position R1 RCM Inc. to attract larger healthcare providers to its products and servic...
Allscripts Healthcare Solutions press release (NASDAQ:MDRX): Q1 Non-GAAP EPS of $0.13. Revenue of $142.7M (+6.7% Y/Y). Generated $35 million of cash flow from continuing operations in the quarter. On a consolidated Allscripts basis Adjusted EBITDA totaled $34 million in the first quarter of 2...
Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) today announced that it has completed the sale of the net assets of the Allscripts Hospital and Large Physician Practices business segment to Constellation Software Inc. (TSX:CSU), through its wholly-owned subsidiary N. Harris Com...
Allscripts Healthcare Solutions, Inc . (NASDAQ:MDRX) will report its financial results for the three months ended March 31, 2022 after the close of stock market hours on Thursday, May 5, 2022. Allscripts management plans to host a conference call and webcast to discuss the company's...
News, Short Squeeze, Breakout and More Instantly...
Allscripts Healthcare Solutions Inc. Company Name:
MDRX Stock Symbol:
NASDAQ Market:
Allscripts Healthcare Solutions Inc. Website:
Payer analytics solutions receive top rankings for Client Satisfaction, Reliability, Best of Breed Technology and Process Improvement Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research ...
For the third consecutive year, the comprehensive set of solutions has been rated the overall #1 provider for small physician practice clearinghouse services Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that...
Veradigm Inc. (OTCMKTS: MDRX, the "Company”), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value. As part of the evaluation process, Veradigm will explore pote...